291 related articles for article (PubMed ID: 27994452)
21. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
22. COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma-COPD overlap syndrome.
Kurashima K; Takaku Y; Ohta C; Takayanagi N; Yanagisawa T; Sugita Y
Int J Chron Obstruct Pulmon Dis; 2016; 11():479-87. PubMed ID: 27019598
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
24. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
25. Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores.
Miravitlles M; Molina J; Quintano JA; Campuzano A; Pérez J; Roncero C;
Int J Chron Obstruct Pulmon Dis; 2018; 13():823-831. PubMed ID: 29563782
[TBL] [Abstract][Full Text] [Related]
26. The impact of coping on the somatic and mental status of patients with COPD: a cross-sectional study.
Papava I; Oancea C; Enatescu VR; Bredicean AC; Dehelean L; Romosan RS; Timar B
Int J Chron Obstruct Pulmon Dis; 2016; 11():1343-51. PubMed ID: 27382270
[TBL] [Abstract][Full Text] [Related]
27. The COPD Assessment Test (CAT) can screen for fatigue among patients with COPD.
Stridsman C; Svensson M; Johansson Strandkvist V; Hedman L; Backman H; Lindberg A
Ther Adv Respir Dis; 2018; 12():1753466618787380. PubMed ID: 30035671
[TBL] [Abstract][Full Text] [Related]
28. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
Ding B; Small M; Bergström G; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
[TBL] [Abstract][Full Text] [Related]
29. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.
Wu Y; Qin J; He J; Shen Y; Wang H; Li Y; Zeng Q; Dong J; An Y; Xiong S; Feng M; Wen F
Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
[TBL] [Abstract][Full Text] [Related]
32. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
[TBL] [Abstract][Full Text] [Related]
33. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
34. Correlation of serum vascular adhesion protein-1 with airflow limitation and quality of life in stable chronic obstructive pulmonary disease.
Amani M; Ghadimi N; Aslani MR; Ghobadi H
Respir Med; 2017 Nov; 132():149-153. PubMed ID: 29229088
[TBL] [Abstract][Full Text] [Related]
35. Is the COPD Assessment Test sensitive for differentiating COPD patients from active smokers and nonsmokers without lung function impairment? A population-based study.
Karloh M; Rocha SAV; Pizzichini MMM; Cavalli F; Matte DL; Pizzichini E;
J Bras Pneumol; 2018; 44(3):213-219. PubMed ID: 30043888
[TBL] [Abstract][Full Text] [Related]
36. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
[TBL] [Abstract][Full Text] [Related]
37. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire.
Núñez A; Esquinas C; Barrecheguren M; Calle M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():3837-3844. PubMed ID: 30538445
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics of stable chronic obstructive pulmonary disease related to systemic inflammation].
Solanes I; Bolíbar I; Llauger MA; Medrano C; Peiró M; Fraga M; Pou MA; Giner J; Freixas M; Plaza V;
Med Clin (Barc); 2012 Oct; 139(10):430-6. PubMed ID: 22766062
[TBL] [Abstract][Full Text] [Related]
40. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.
Liu SF; Wang CC; Chin CH; Chen YC; Lin MC
Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
